Search research articles
Contact Us
Filters
Showing results (301-310 of 315) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
H M Kantarjian, S O'Brien, T L Smith, et al.
Oncogene
|
June 7, 2011
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
D B Badgwell, Z Lu, K Le, et al.
Leukemia
|
August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting
M Varella-Garcia, C J Hogan, L F Odom, et al.
Blood
|
September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study
S Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.
Leukemia
|
November 11, 1999
Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid
M Andreeff, S Jiang, X Zhang, et al.
British Journal of Anaesthesia
|
June 5, 2019
Measurement of relative lung perfusion with electrical impedance and positron emission tomography: an experimental comparative study in pigs
T Bluth, T Kiss, M Kircher, et al.
Blood Cancer Journal
|
February 18, 2017
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
Y Nishida, A Maeda, M J Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 17, 1999
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
A H Sarris, K O Kliche, P Pethambaram, et al.
Leukemia
|
February 4, 2014
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia
F Ravandi, C Arana Yi, J E Cortes, et al.
Blood Cancer Journal
|
March 11, 2017
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia
G L Uy, M P Rettig, R M Stone, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 315) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
H M Kantarjian, S O'Brien, T L Smith, et al.
Oncogene
|
June 7, 2011
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
D B Badgwell, Z Lu, K Le, et al.
Leukemia
|
August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting
M Varella-Garcia, C J Hogan, L F Odom, et al.
Blood
|
September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study
S Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.
Leukemia
|
November 11, 1999
Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid
M Andreeff, S Jiang, X Zhang, et al.
British Journal of Anaesthesia
|
June 5, 2019
Measurement of relative lung perfusion with electrical impedance and positron emission tomography: an experimental comparative study in pigs
T Bluth, T Kiss, M Kircher, et al.
Blood Cancer Journal
|
February 18, 2017
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
Y Nishida, A Maeda, M J Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 17, 1999
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
A H Sarris, K O Kliche, P Pethambaram, et al.
Leukemia
|
February 4, 2014
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia
F Ravandi, C Arana Yi, J E Cortes, et al.
Blood Cancer Journal
|
March 11, 2017
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia
G L Uy, M P Rettig, R M Stone, et al.
Page
of 32